SECsense Logo

Moleculin Biotech, Inc. 8-K Report: Key Updates and Future Insights

$MBRX
Form 8-K
Filed on: 2025-02-13
Source
Moleculin Biotech, Inc. 8-K Report: Key Updates and Future Insights

Based on the provided XML section of the financial report, here are the key pieces of information extracted:

  1. Filing Type: The report is an 8-K, which is a form used by public companies to report significant events that shareholders should know about.
  2. Company Information:
  • Name: Moleculin Biotech, Inc.
  • State of Incorporation: Delaware (DE)
  • CIK (Central Index Key): 0001659617
  • SEC File Number: 001-37758
  • EIN (Employer Identification Number): 47-4671997
  • Address: 5300 Memorial Drive Suite 950, Houston, TX 77007
  • Phone Number: 713-300-5160
  1. Stock Information:
  • Common Stock: The par value is $0.001 per share.
  • Ticker Symbol: MBRX
  • Exchange: NASDAQ
  1. Period of Report:
  • Start Date: February 13, 2025
  • End Date: February 13, 2025

Insights:

  • The filing indicates a significant event or update from Moleculin Biotech, which may be of interest to investors or analysts tracking the company's performance or potential changes.
  • The report is dated for a future event, suggesting it may pertain to an upcoming corporate action or announcement scheduled for that date.
  • The company is listed on NASDAQ, which provides context for its market presence and investor relations.

This summary encapsulates the essential details from the XML snippet, reflecting the company's identity, stock characteristics, and the nature of the filing.